The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Depressive Disorder-Global Market Insights and Sales Trends 2024
Synopsis
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.
The global Depressive Disorder market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Depressive Disorder in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Homecare Settings, are propelling Depressive Disorder market. Tricyclic Antidepressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Serotonin Reuptake Inhibitors segment is estimated at % CAGR for the next seven-year period.
The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Depressive Disorder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Depressive Disorder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Depressive Disorder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Depressive Disorder sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Depressive Disorder covered in this report include Alkermes, Allergan, Bristol Myers Squibb, Eli Lilly, Glaxosmithkline, H. Lundbeck, Merck, Pfizer and Teva Pharmaceutical, etc.
The global Depressive Disorder market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
Takeda Pharmaceutical
Global Depressive Disorder market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Depressive Disorder market, Segment by Type:
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Others
Global Depressive Disorder market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Long Term Care Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Depressive Disorder companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including genes, factors such as stress and brain chemistry that could lead to depression.
The global Depressive Disorder market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Depressive Disorder in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Homecare Settings, are propelling Depressive Disorder market. Tricyclic Antidepressants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Selective Serotonin Reuptake Inhibitors segment is estimated at % CAGR for the next seven-year period.
The Depressive Disorder market will undergo a period of steady growth from 2015 to 2025, mainly attributed to the growth in atypical antipsychotics and the expected launch of five pipeline.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Depressive Disorder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Depressive Disorder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Depressive Disorder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Depressive Disorder sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Depressive Disorder covered in this report include Alkermes, Allergan, Bristol Myers Squibb, Eli Lilly, Glaxosmithkline, H. Lundbeck, Merck, Pfizer and Teva Pharmaceutical, etc.
The global Depressive Disorder market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
Glaxosmithkline
H. Lundbeck
Merck
Pfizer
Teva Pharmaceutical
Takeda Pharmaceutical
Global Depressive Disorder market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Depressive Disorder market, Segment by Type:
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist And Reuptake Inhibitors
Others
Global Depressive Disorder market, by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Homecare Settings
Long Term Care Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Depressive Disorder companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Depressive Disorder
1.1 Depressive Disorder Market Overview
1.1.1 Depressive Disorder Product Scope
1.1.2 Depressive Disorder Market Status and Outlook
1.2 Global Depressive Disorder Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Depressive Disorder Market Size by Region (2018-2029)
1.4 Global Depressive Disorder Historic Market Size by Region (2018-2023)
1.5 Global Depressive Disorder Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Depressive Disorder Market Size (2018-2029)
1.6.1 North America Depressive Disorder Market Size (2018-2029)
1.6.2 Europe Depressive Disorder Market Size (2018-2029)
1.6.3 Asia-Pacific Depressive Disorder Market Size (2018-2029)
1.6.4 Latin America Depressive Disorder Market Size (2018-2029)
1.6.5 Middle East & Africa Depressive Disorder Market Size (2018-2029)
2 Depressive Disorder Market by Type
2.1 Introduction
2.1.1 Tricyclic Antidepressants
2.1.2 Selective Serotonin Reuptake Inhibitors
2.1.3 Serotonin-Norepinephrine Reuptake Inhibitors
2.1.4 Monoamine Oxidase Inhibitors
2.1.5 Serotonin Antagonist And Reuptake Inhibitors
2.1.6 Others
2.2 Global Depressive Disorder Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Depressive Disorder Historic Market Size by Type (2018-2023)
2.2.2 Global Depressive Disorder Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Depressive Disorder Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Depressive Disorder Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Depressive Disorder Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Depressive Disorder Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Depressive Disorder Revenue Breakdown by Type (2018-2029)
3 Depressive Disorder Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Diagnostic Centers
3.1.4 Homecare Settings
3.1.5 Long Term Care Centers
3.2 Global Depressive Disorder Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Depressive Disorder Historic Market Size by Application (2018-2023)
3.2.2 Global Depressive Disorder Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Depressive Disorder Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Depressive Disorder Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Depressive Disorder Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Depressive Disorder Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Depressive Disorder Revenue Breakdown by Application (2018-2029)
4 Depressive Disorder Competition Analysis by Players
4.1 Global Depressive Disorder Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Depressive Disorder as of 2022)
4.3 Date of Key Players Enter into Depressive Disorder Market
4.4 Global Top Players Depressive Disorder Headquarters and Area Served
4.5 Key Players Depressive Disorder Product Solution and Service
4.6 Competitive Status
4.6.1 Depressive Disorder Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alkermes
5.1.1 Alkermes Profile
5.1.2 Alkermes Main Business
5.1.3 Alkermes Depressive Disorder Products, Services and Solutions
5.1.4 Alkermes Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.1.5 Alkermes Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Depressive Disorder Products, Services and Solutions
5.2.4 Allergan Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.2.5 Allergan Recent Developments
5.3 Bristol Myers Squibb
5.3.1 Bristol Myers Squibb Profile
5.3.2 Bristol Myers Squibb Main Business
5.3.3 Bristol Myers Squibb Depressive Disorder Products, Services and Solutions
5.3.4 Bristol Myers Squibb Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.3.5 Eli Lilly Recent Developments
5.4 Eli Lilly
5.4.1 Eli Lilly Profile
5.4.2 Eli Lilly Main Business
5.4.3 Eli Lilly Depressive Disorder Products, Services and Solutions
5.4.4 Eli Lilly Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.4.5 Eli Lilly Recent Developments
5.5 Glaxosmithkline
5.5.1 Glaxosmithkline Profile
5.5.2 Glaxosmithkline Main Business
5.5.3 Glaxosmithkline Depressive Disorder Products, Services and Solutions
5.5.4 Glaxosmithkline Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.5.5 Glaxosmithkline Recent Developments
5.6 H. Lundbeck
5.6.1 H. Lundbeck Profile
5.6.2 H. Lundbeck Main Business
5.6.3 H. Lundbeck Depressive Disorder Products, Services and Solutions
5.6.4 H. Lundbeck Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.6.5 H. Lundbeck Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Depressive Disorder Products, Services and Solutions
5.7.4 Merck Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.7.5 Merck Recent Developments
5.8 Pfizer
5.8.1 Pfizer Profile
5.8.2 Pfizer Main Business
5.8.3 Pfizer Depressive Disorder Products, Services and Solutions
5.8.4 Pfizer Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Recent Developments
5.9 Teva Pharmaceutical
5.9.1 Teva Pharmaceutical Profile
5.9.2 Teva Pharmaceutical Main Business
5.9.3 Teva Pharmaceutical Depressive Disorder Products, Services and Solutions
5.9.4 Teva Pharmaceutical Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Pharmaceutical Recent Developments
5.10 Takeda Pharmaceutical
5.10.1 Takeda Pharmaceutical Profile
5.10.2 Takeda Pharmaceutical Main Business
5.10.3 Takeda Pharmaceutical Depressive Disorder Products, Services and Solutions
5.10.4 Takeda Pharmaceutical Depressive Disorder Revenue (US$ Million) & (2018-2023)
5.10.5 Takeda Pharmaceutical Recent Developments
6 North America
6.1 North America Depressive Disorder Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Depressive Disorder Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Depressive Disorder Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Depressive Disorder Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Depressive Disorder Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Depressive Disorder Market Dynamics
11.1 Depressive Disorder Industry Trends
11.2 Depressive Disorder Market Drivers
11.3 Depressive Disorder Market Challenges
11.4 Depressive Disorder Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
